Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Avalon GloboCare ( (ALBT) ) just unveiled an announcement.
On April 15, 2025, Avalon GloboCare Corp. announced a partnership with SpecialtyHealth, Inc. to enhance the BrAce 4 Impact Challenge, a fitness initiative for police chiefs, using the KetoAir breathalyzer. This collaboration, which began on April 1, 2024, aims to integrate ketogenic health management into law enforcement wellness programs, providing real-time ketone level tracking to support healthier lifestyle choices for participants. The initiative reflects Avalon’s commitment to innovative health solutions and strengthens its position in the precision diagnostics market.
More about Avalon GloboCare
Avalon GloboCare Corp. is a commercial-stage company focused on developing and delivering precision diagnostic consumer products and advancing intellectual property in cellular therapy. The company markets the KetoAir™ breathalyzer device, which is registered with the U.S. Food and Drug Administration as a Class I medical device, and is also involved in commercial real estate.
YTD Price Performance: 10.50%
Average Trading Volume: 72,158
Technical Sentiment Signal: Strong Buy
Current Market Cap: $6.26M
Learn more about ALBT stock on TipRanks’ Stock Analysis page.